| 59.4% |  | United States |
| 8.7% |  | United Kingdom |
| 5% |  | Canada |
| 4% |  | Australia |
| 3.5% |  | Philippines |
| 2.6% |  | Netherlands |
| 2.4% |  | India |
| 1.6% |  | Germany |
| 1% |  | France |
| 0.7% |  | Poland |
| Today: | 225 |
| Yesterday: | 251 |
| This Week: | 225 |
| Last Week: | 2221 |
| This Month: | 4813 |
| Last Month: | 6796 |
| Total: | 129412 |
Cost benefit analyses of prohibition and regulation.
Monday, 06 April 2009 00:00 | 
Written by Administrator | 
| 
| 
Drug Abuse
Dear Colleague
Today Transform Drug Policy Foundation published a report comparing cost
benefit analyses of prohibition and regulation.
See the report and the coverage here:
http://tinyurl.com/ccz8vo
We would encourage all those on all sides of the debate to support an impact
assessment in order to gather evidence for assessing policy effectiveness
and to explore alternatives.
There is every reason why this work should take place in other nation states
and at UN levels.
Danny Kushlick
Head of Policy and Communications
Transform Drug Policy Foundation
Easton Business Centre
Felix Road
Easton
Bristol BS5 0HE
tel: +44 (0)117 941 5810
email:
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
web: www.tdpf.org.uk
To subscribe to Transform's newsletter visit:
Last Updated (Wednesday, 05 January 2011 20:01)